Annex
United Kingdom
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following:
Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Rafoxanide Rafoxanide Bovine 30 μg/kg Muscle NO ENTRY Antiparasitic agents/Agents against endoparasites’ 30 μg/kg Fat 10 μg/kg Liver 40 μg/kg Kidney Ovine 100 μg/kg Muscle 250 μg/kg Fat 150 μg/kg Liver 150 μg/kg Kidney Bovine, ovine 10 μg/kg Milk Provisional MRL shall expire on 31 December 2015